The ACRIN 6657-extension trial, the first multi-center trial using magnetic resonance spectroscopy (MRS) in breast cancer, has completed and its initial results have been recently published. This study reports on the quality of the MRS data and identifies technical and logistic factors that contributed to a lower-than-anticipated data yield.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords